Asia Healthcare Holdings (AHH), a healthcare platform focused on single-speciality hospitals, announced that GIC, Singapore’s sovereign wealth fund, will invest an additional $150m in the company.
This follows GIC’s initial $170m investment in AHH in February 2022.
AHH, a healthcare delivery platform based in India, focuses on investing in and growing different single-speciality healthcare companies under one enterprise.
To date, AHH has invested around $300m across oncology, mother & childcare, urology & nephrology, and IVF & fertility sectors.
Asia Healthcare Holdings executive chairman Vishal Bali said: “We started AHH as a healthcare delivery platform that would invest, transform and grow single speciality enterprises under one holding company.
“Over the years, our differentiated investment approach has since delivered strong growth opportunities to bridge the demand-supply gap of healthcare services in India.
“Together with our seasoned leadership team, targeted investments in cutting-edge medical technology and steadfast focus on providing quality care to patients, we have successfully transformed our single speciality healthcare enterprises into market leaders within a short period of time.”
AHH’s platform includes healthcare brands such as Motherhood Hospitals, Nova IVF, and the Asian Institute of Nephrology & Urology (AINU).
Motherhood is a pan-India chain specialising in mother and childcare hospitals, offering comprehensive services from pre-conception to post-birthing care for women, along with a network of services under paediatric care, including the network of Neonatal Intensive Care Units (NICU).
Nova IVF is a fertility solutions provider, delivering IVF services across South Asia.
AINU is an India-based specialised Urology & Nephrology hospital network, known for advanced urological care, robotic surgery, and high-end nephrology procedures.
According to GIC, these entities have achieved market leadership in their respective verticals and regions under AHH.
GIC private equity chief investment officer Choo Yong Cheen said: “We are pleased to continue supporting AHH’s growth with our long-term capital, global network, and resources.
“As a long-term investor, we are confident in India’s single speciality healthcare sector, which has strong tailwinds for growth driven by increasing per capita income, urbanisation, high awareness of speciality care, and improved supply of high-quality clinics.
“AHH’s potential to expand into newer sub-segments positions it well for continued success.”
